News & Analysis on Clinical Trial Services & Contract Research And Development
Merck has been forced to delay marketing plans for its combination cholesterol drug MK-0524B following problems in formulating its top-selling statin Zocor (simvastatin) with a new promising compound under development, MK-524A.
Roche spokesperson Chris Kirkpatrick speaks on the advantages of using a contractor as a research partner at the recent Pabord pharmaceutical show in London.
Researchers have discovered a new method for delivering drugs to the eye using biodegradable polymer nanoparticles that promise controlled release and better bioavailability than eye drops.
A majority stake in Irish biotechnology contract services firm Archport has been snapped up by German-based Chemie Uetikon as the bio-outsourcing market heats up.
As India's clinical trials industry continues to explode, lack of experienced clinical research employees in the region is slowing down progress and leading to fierce poaching between firms.
The US Food and Drug Administration (FDA) has issued new advice to aid manufacturers in developing safe and effective cell-based viral vaccines, hoping it can modernise America's manufacturing network and speed up production.
Dr. Reddy's Laboratories has announced the inauguration of its seventh finished dosage plant in India, reflecting the country's unprecedented growth as a generic pharmaceuticals manufacturer.